BRPI0914745A2 - composição nutricional - Google Patents

composição nutricional

Info

Publication number
BRPI0914745A2
BRPI0914745A2 BRPI0914745A BRPI0914745A BRPI0914745A2 BR PI0914745 A2 BRPI0914745 A2 BR PI0914745A2 BR PI0914745 A BRPI0914745 A BR PI0914745A BR PI0914745 A BRPI0914745 A BR PI0914745A BR PI0914745 A2 BRPI0914745 A2 BR PI0914745A2
Authority
BR
Brazil
Prior art keywords
nutritional composition
nutritional
composition
Prior art date
Application number
BRPI0914745A
Other languages
English (en)
Inventor
Adrianus Lambertus Bertholdus Van Helvoort
Arjan Paul Vos
Cornelus Johannes Petrus Van Limpt
Joyce Faber
Klaske Van Norren
Robert Johan Joseph Hageman
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40380361&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0914745(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of BRPI0914745A2 publication Critical patent/BRPI0914745A2/pt
Publication of BRPI0914745B1 publication Critical patent/BRPI0914745B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0914745-4A 2008-06-23 2009-06-23 composição nutricional BRPI0914745B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NLPCT/NL2008/050414 2008-06-23
PCT/NL2008/050414 WO2009157759A1 (en) 2008-06-23 2008-06-23 Nutritional composition for improving the mammalian immune system
PCT/NL2009/050370 WO2009157767A1 (en) 2008-06-23 2009-06-23 Nutritional composition for improving the mammalian immune system

Publications (2)

Publication Number Publication Date
BRPI0914745A2 true BRPI0914745A2 (pt) 2015-10-20
BRPI0914745B1 BRPI0914745B1 (pt) 2021-01-26

Family

ID=40380361

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0914745-4A BRPI0914745B1 (pt) 2008-06-23 2009-06-23 composição nutricional

Country Status (12)

Country Link
US (2) US20110150824A1 (pt)
EP (1) EP2296643B1 (pt)
CN (1) CN102131502B (pt)
BR (1) BRPI0914745B1 (pt)
DK (1) DK2296643T3 (pt)
ES (1) ES2582002T3 (pt)
HU (1) HUE029049T2 (pt)
MX (1) MX2011000022A (pt)
PL (1) PL2296643T3 (pt)
PT (1) PT2296643T (pt)
RU (1) RU2525429C2 (pt)
WO (2) WO2009157759A1 (pt)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2450815C2 (ru) 2005-12-16 2012-05-20 Н.В. Нютрисиа Применение растворимых пищевых волокон против мышечной атрофии
WO2009157759A1 (en) 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system
PT2374452T (pt) 2008-12-05 2019-10-31 Ajinomoto Kk Composição de nutrientes
NL1037147C2 (nl) * 2009-07-23 2011-01-25 Opus Trade B V Samenstelling, werkwijze voor het produceren ervan en het gebruik ervan.
IT1399244B1 (it) * 2009-07-31 2013-04-11 Pharmarte S R L Formulazione di barretta specifica per la gravidanza.
US9585920B2 (en) 2011-02-04 2017-03-07 Katherine Rose Kovarik Method and system for treating cancer cachexia
US9457077B2 (en) 2009-11-18 2016-10-04 Katherine Rose Kovarik Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases
JP2013529193A (ja) * 2010-04-26 2013-07-18 ネステク ソシエテ アノニム 非経口栄養から経腸栄養へ離脱させるための栄養組成物及び方法
EP2444083A1 (en) * 2010-10-21 2012-04-25 Nestec S.A. Cysteine and food intake
KR101743488B1 (ko) * 2010-11-30 2017-06-07 (주)아모레퍼시픽 비피더스균 추출물을 함유하는 지방유래 줄기세포의 줄기세포성 증진용 및 피부세포 증식용 조성물
US20120197067A1 (en) * 2011-01-31 2012-08-02 Primeval B.V. Nutritional Composition for Equine Reproductive Health
US10940169B2 (en) 2015-11-30 2021-03-09 Joseph E. Kovarik Method for reducing the likelihood of developing cancer in an individual human being
US9730967B2 (en) 2011-02-04 2017-08-15 Katherine Rose Kovarik Method and system for treating cancer cachexia
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US12279989B2 (en) 2011-02-04 2025-04-22 Seed Health, Inc. Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
US10314865B2 (en) 2011-02-04 2019-06-11 Katherine Rose Kovarik Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US12533312B2 (en) 2011-02-04 2026-01-27 Seed Health, Inc. Method and system for preventing sore throat in humans
US12257272B2 (en) 2015-12-24 2025-03-25 Seed Health, Inc. Method and system for reducing the likelihood of developing depression in an individual
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
WO2012141575A1 (en) * 2011-04-14 2012-10-18 N.V.Nutricia Combination of epa, dpa and/or dha with a chemotherapeutic agent
WO2012177118A1 (en) 2011-06-22 2012-12-27 N.V. Nutricia Method for reducing the occurrence of infection in young children
RU2485964C1 (ru) * 2012-01-10 2013-06-27 Сергей Александрович Староверов Иммуностимулирующая композиция для животных
WO2013186233A1 (en) * 2012-06-12 2013-12-19 Norwegian University Of Science And Technology Composition
US9241923B2 (en) * 2013-07-16 2016-01-26 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US11672835B2 (en) 2013-12-20 2023-06-13 Seed Health, Inc. Method for treating individuals having cancer and who are receiving cancer immunotherapy
US11026982B2 (en) 2015-11-30 2021-06-08 Joseph E. Kovarik Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US12329783B2 (en) 2013-12-20 2025-06-17 Seed Health, Inc. Method and system to improve the health of a person's skin microbiome
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
US11529379B2 (en) 2013-12-20 2022-12-20 Seed Health, Inc. Method and system for reducing the likelihood of developing colorectal cancer in an individual human being
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11642382B2 (en) 2013-12-20 2023-05-09 Seed Health, Inc. Method for treating an individual suffering from bladder cancer
US11213552B2 (en) 2015-11-30 2022-01-04 Joseph E. Kovarik Method for treating an individual suffering from a chronic infectious disease and cancer
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
EP3134385A1 (en) 2014-04-25 2017-03-01 Ajinomoto Co., Inc. Immunostimulating agent
CN103976359B (zh) * 2014-05-23 2016-01-13 汤臣倍健股份有限公司 食品营养强化组合物及其应用、保健食品及其制备方法
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
RU2608051C1 (ru) * 2015-07-03 2017-01-12 Махмуд Омарович Омаров Кормовая добавка для собак с антиоксидантным и иммуностимулирующим действием
JP2018536645A (ja) 2015-10-28 2018-12-13 味の素株式会社 免疫賦活剤
CN105231461A (zh) * 2015-10-30 2016-01-13 中营康园（北京）科技有限公司 一种提高机体免疫力的营养组合物及其应用
KR20180093903A (ko) 2015-11-03 2018-08-22 더 브리검 앤드 우먼즈 하스피털, 인크. 음식 알레르기의 치료 및/또는 예방을 위한 치료용 미생물총
CN108430490A (zh) * 2015-12-03 2018-08-21 株式会社明治 营养组合物
WO2017110988A1 (ja) * 2015-12-25 2017-06-29 大塚製薬株式会社 ゲル状食品組成物
GB201602626D0 (en) 2016-02-15 2016-03-30 Alchemy Foodtech Pte Ltd And Goh Zhi M V Glycemic reducing composition
HU231044B1 (hu) 2016-07-22 2020-01-28 Culex Patent Kft. Liponsav és szelenit szinergista hatásán alapuló készítmény és annak alkalmazása daganatos megbetegedések megelőzésében és kezelésében
CN106307504A (zh) * 2016-08-24 2017-01-11 华仁药业股份有限公司 一种用于慢性肾病患者的肠内营养组合物及其制备方法
US11206861B2 (en) 2016-10-03 2021-12-28 Houn Simon Hsia Compositions and methods for enhancing cancer radiotherapy
KR102775757B1 (ko) * 2017-06-13 2025-02-28 호운 사이먼 샤 암 방사선요법을 향상시키기 위한 조성물 및 방법
WO2018231943A2 (en) 2017-06-13 2018-12-20 Houn Simon Hsia Compositions and methods for enhancing cancer chemotherapy
CA3066742A1 (en) 2017-06-13 2018-12-20 Houn Simon Hsia Compositions and methods for enhancing hyperthermia therapy
CN108851038A (zh) * 2018-05-08 2018-11-23 山东理工大学 糖尿病并发症肾病营养食品及其制备方法
PL3813549T3 (pl) 2018-06-27 2026-03-09 Arla Foods Amba Preparat napoju z beta-laktoglobuliną o obojętnym ph
WO2020043797A1 (en) * 2018-08-29 2020-03-05 Dsm Ip Assets B.V. Formulations for improving gut health
EP3930735A1 (en) 2019-02-26 2022-01-05 The Regents of the University of Colorado, a body corporate Method and composition for treating gastrointestinal inflammatory disorders
EP3969009B1 (en) 2019-05-15 2025-08-20 N.V. Nutricia Beta-1,3'-galactosyllactose for the treatment of gut barrier function diseases
WO2021053447A1 (en) * 2019-09-17 2021-03-25 Amitojas Wellness Private Limited Nutrition supplement for cancer patients
EP4061399B1 (en) 2019-11-20 2024-02-14 Arla Foods amba Insulinotropic and glucagonotropic effects of beta-lactoglobulin
CN110882282A (zh) * 2019-12-13 2020-03-17 唐晓磊 一种调理肿瘤病患放化疗后肠道菌群失调的益生菌制剂及其应用
CN110960672B (zh) * 2019-12-18 2020-10-16 西南民族大学 一种提高牦牛免疫能力的aif-1蛋白注射液
CN111840523B (zh) * 2020-08-24 2021-08-31 中国农业科学院北京畜牧兽医研究所 一种含活性蛋白和活性脂肪酸的抗癌症的药物组合物
IT202200018804A1 (it) * 2022-09-14 2024-03-14 Abiogen Pharma Spa Composizione comprendente l-leucina e olio di pesce
CN116762952A (zh) * 2023-06-30 2023-09-19 西藏多欣健康科技有限公司 一种流质配方食品及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
EP1372641A4 (en) 2001-03-05 2004-08-25 Stephen P Ernest ENTERAL FORMULATION
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
JP4970694B2 (ja) * 2002-12-02 2012-07-11 株式会社明治 持続性筋肉疲労改善剤
GB0300602D0 (en) 2003-01-10 2003-02-12 Forinnova As Compositions
DK1629850T4 (da) * 2004-08-24 2013-07-01 Nutricia Nv Næringssammensætning indeholdende ufordøjelige oligosaccharider
EP1774973A1 (en) * 2005-10-12 2007-04-18 Nutricia N.V. Leucine rich composition
US20070116802A1 (en) 2005-11-23 2007-05-24 Carl Germano High quality caloric composition
RU2450815C2 (ru) 2005-12-16 2012-05-20 Н.В. Нютрисиа Применение растворимых пищевых волокон против мышечной атрофии
WO2007114683A1 (en) * 2006-03-30 2007-10-11 N.V. Nutricia Milk oligosaccharides for stimulating the immune system
CN101472612B (zh) * 2006-06-14 2011-06-08 纽崔西亚公司 包含甘氨酸和乳铁蛋白的抗炎组合物及其应用
WO2008046870A1 (en) * 2006-10-19 2008-04-24 Nestec S.A. Long-term feed - cancer patient
WO2009157759A1 (en) 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system

Also Published As

Publication number Publication date
EP2296643A1 (en) 2011-03-23
PL2296643T3 (pl) 2016-11-30
PT2296643T (pt) 2016-07-19
RU2011102393A (ru) 2012-07-27
WO2009157759A1 (en) 2009-12-30
BRPI0914745B1 (pt) 2021-01-26
DK2296643T3 (en) 2016-08-01
CN102131502B (zh) 2014-12-03
WO2009157767A1 (en) 2009-12-30
US20110150824A1 (en) 2011-06-23
MX2011000022A (es) 2011-03-29
EP2296643B1 (en) 2016-04-20
CN102131502A (zh) 2011-07-20
US20150004130A1 (en) 2015-01-01
HUE029049T2 (en) 2017-01-30
RU2525429C2 (ru) 2014-08-10
US10449248B2 (en) 2019-10-22
ES2582002T3 (es) 2016-09-08

Similar Documents

Publication Publication Date Title
FIC20220024I1 (fi) Anifrolumabi
BRPI1010709A2 (pt) composição nutricional
BRPI0906749A2 (pt) Composição
BRPI0913808A2 (pt) composição
DK2634232T3 (da) Sammensætninger
DE602008002756D1 (de) Bauzusammensetzung
EP2381760A4 (en) CORN PROTEIN COMPOSITION
BRPI0917231A2 (pt) composição
BRPI0821714A2 (pt) Composições comestíveis
EP2374452A4 (en) NUTRIENT COMPOSITION
BRPI0907376A2 (pt) Fotobiorretador
BRPI0813775A2 (pt) Composição
IT1392101B1 (it) Composizione comprendente isoflavoni
ATE528048T1 (de) Schweisshemmende/desodorierende zusammensetzung
BRPI0810557A2 (pt) composição
BRPI0811274A2 (pt) Composição
BRPI0919718A2 (pt) Composição nutricional com propriedades antirregurgitação
BRPI0914940A2 (pt) composições nutritivas contendo punicalaginas
EP2280264A4 (en) STANDARD AGENTS
PT2182988E (pt) Composição radiofarmacêutica
PT2309878T (pt) Purgantes dietéticos
DE602009000862D1 (de) Gehwagenbremse
BRPI0811002A2 (pt) Composição biofertilizante
DE112009001946A5 (de) Mobelauszugsführung
BRPI0820960A2 (pt) composição

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 39/39 (2006.01), A23L 33/12 (2016.01), A23L 3

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/01/2021, OBSERVADAS AS CONDICOES LEGAIS.